Evidence map›Paper›PMID 39337380›Full record

ArticleInternational journal of molecular sciences2024

Fiamma Gláucia-Silva, João Vicente Pereira Torres, Manoela Torres-Rêgo, Alessandra Daniele-Silva, Allanny Alves Furtado, Sarah de Sousa Ferreira, Guilherme Maranhão Chaves, Francisco Humberto Xavier-Júnior, Karla Samara Rocha Soares, Arnóbio Antônio da Silva-Júnior and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fiamma Gláucia-SilvaLaboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), Faculty of Pharmacy, Federal University of Rio Grande do Norte, General Gustavo Cordeiro de Farias Avenue, S/N, Petrópolis, Natal 59012-570, Brazil.
João Vicente Pereira TorresLaboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), Faculty of Pharmacy, Federal University of Rio Grande do Norte, General Gustavo Cordeiro de Farias Avenue, S/N, Petrópolis, Natal 59012-570, Brazil.ORCID 0009-0008-2081-4120
Manoela Torres-RêgoLaboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), Faculty of Pharmacy, Federal University of Rio Grande do Norte, General Gustavo Cordeiro de Farias Avenue, S/N, Petrópolis, Natal 59012-570, Brazil.
Alessandra Daniele-SilvaLaboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), Faculty of Pharmacy, Federal University of Rio Grande do Norte, General Gustavo Cordeiro de Farias Avenue, S/N, Petrópolis, Natal 59012-570, Brazil.
Allanny Alves FurtadoLaboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), Faculty of Pharmacy, Federal University of Rio Grande do Norte, General Gustavo Cordeiro de Farias Avenue, S/N, Petrópolis, Natal 59012-570, Brazil.
Sarah de Sousa FerreiraLaboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), Faculty of Pharmacy, Federal University of Rio Grande do Norte, General Gustavo Cordeiro de Farias Avenue, S/N, Petrópolis, Natal 59012-570, Brazil.
Guilherme Maranhão ChavesLaboratory of Medical and Molecular Micology, Department of Clinical and Toxicological Analyses, Faculty of Pharmacy, Federal University of Rio Grande do Norte, General Gustavo Cordeiro de Farias Avenue, S/N, Petrópolis, Natal 59012-570, Brazil.ORCID 0000-0002-0170-9383
Francisco Humberto Xavier-JúniorLaboratory of Pharmaceutical Biotechnology (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraiba, Campus Universitário I, Castelo Branco III, Cidade Universitária, João Pessoa 58051-900, Brazil.ORCID 0000-0001-8238-3380
Karla Samara Rocha SoaresLaboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), Faculty of Pharmacy, Federal University of Rio Grande do Norte, General Gustavo Cordeiro de Farias Avenue, S/N, Petrópolis, Natal 59012-570, Brazil.
Arnóbio Antônio da Silva-JúniorLaboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), Faculty of Pharmacy, Federal University of Rio Grande do Norte, General Gustavo Cordeiro de Farias Avenue, S/N, Petrópolis, Natal 59012-570, Brazil.ORCID 0000-0002-7516-1787
Matheus de Freitas Fernandes-PedrosaLaboratory of Technology and Pharmaceutical Biotechnology (Tecbiofar), Faculty of Pharmacy, Federal University of Rio Grande do Norte, General Gustavo Cordeiro de Farias Avenue, S/N, Petrópolis, Natal 59012-570, Brazil.ORCID 0000-0003-4221-9580

Funding

Brazilian Agencies of Coordination of Improvement and Evaluation of Graduate Studies (CAPES, Finance Code 001)Brazilian Agencies of Coordination of Improvement and Evaluation of Graduate Studies grant numbers: 23038000814/2011-83National Council for Scientific and Technological Development (CNPq) process number: 442006/2018-7.
6 · The paper itself

Abstract

The rapid resistance developed by pathogenic microorganisms against the current antimicrobial pool represents a serious global public health problem, leading to the search for new antibiotic agents. The scorpion

Indexed as

ChitosanMicrobial Sensitivity TestsNanoparticlesScorpionsScorpion VenomsAnimalsAnimals, PoisonousAnti-Bacterial AgentsAnti-Infective AgentsCandidaParticle SizeStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsChitosanScorpion Venomsantimicrobialbiodegradable nanocarrierchitosannanoparticleTityus stigmurus scorpion

Identifiers

PMID39337380
PMCPMC11432167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.